Colorectal Cancer Clinical Trials in Massachusetts

Showing 121-135 of 135 trials

Improving Followup of Abnormal Colon Cancer Screening Tests

NCT00436137

The purpose of this study is to determine whether direct mailings to patients with positive fecal occult blood tests can increase rates of performing followup colonoscopy.

Colorectal Cancer

Harvard Vanguard Medical Associates70 participantsStarted Jun 2007

Newton, Massachusetts, United States

COMPLETEDPHASE222 miles

SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to Fluorouracil

NCT00003254

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Ethynyluracil may help fluorouracil kill more cancer cells by making tumor cells more sensitive to the drug. PURPOSE: Phase II trial to study the effectiveness of fluorouracil plus ethynyluracil in treating patients with advanced colorectal cancer that has not responded to fluorouracil.

Colorectal Cancer

SWOG Cancer Research Network75 participantsStarted Apr 1998

Mobile, Alabama, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +83 more locations

Improving Followup of Abnormal Colon Cancer Screening Tests

SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to Fluorouracil

Colorectal Cancer Trials in Other Cities

Population-Based Patient-Centric Care: Comprehensive Preventive Cancer Screening Using Health IT

Educational CD-ROM Compared With Standard Informed Consent for Patients With Colorectal Cancer or a Family History of Colorectal Cancer

Educational Intervention With or Without Telephone Counseling in Increasing Colorectal Cancer Screening Compliance in Brothers and Sisters of Patients With Colorectal Cancer

Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer

FR901228 in Treating Patients With Previously Treated Unresectable Locally Advanced or Metastatic Colorectal Cancer

Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal Cancer

ZD 1839 Plus Combination Chemotherapy in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Colorectal Cancer

Computerized Tomographic Colonography Compared With Standard Diagnostic Procedures in Detecting Colorectal Neoplasia

Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers

Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer

GM-CT-01 Plus 5-Fluorouracil as Third- or Fourth-Line Therapy for Metastatic Colorectal Cancer

Monoclonal Antibody F19 in Treating Patients With Advanced or Metastatic Cancer

Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal Cancer

Other Conditions in Massachusetts